FDA updates labeling for BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Labeling changes approved for LGM PHARMA. Active ingredient: ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE. Decision date: 12/22/2025
Labeling changes approved for LGM PHARMA. Active ingredient: ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE. Decision date: 12/22/2025
There are no comments here yet...